89 Results for "

Bim

" in MedChemExpress (MCE) Product Catalog:
Products (89)

89 Results for "Bim" in MCE Product Catalog:

  • Categories Recommended:
    More
79
79 Publications Verification
製品番号: HY-50907
CAS 番号: 852808-04-9
ABT-737, a BH3 mimetic, is a potent Bcl-2, Bcl-xL and Bcl-w inhibitor with EC50s of 30.3 nM, 78.7 nM, and 197.8 nM, respectively. ABT-737 induces the disruption of the BCL-2/BAX complex and BAK-dependent but BIM-independent activation of the intrinsic apoptotic pathway. ABT-737 induces autophagy and has the potential for acute myeloid leukemia (AML) research .
loading...
    loading...
15
15 Cited Publications
製品番号: HY-50868
CAS 番号: 859212-16-1
別名: INNO-406; NS-187
Target:  

Bcr-Abl Src Apoptosis

研究分野:  

Cancer

Bafetinib is an orally active Lyn/Bcr-Abl tyrosine kinase inhibitor. Bafetinib enhances the activity of several pro-apoptotic Bcl-2 homology (BH) 3-pure proteins (Bim, Bad, Bmf, and Bik) through intrinsic apoptotic pathways regulated by the Bcl-2 family, and induces apoptosis of Ph + leukemia cells. Bafetinib has antitumor activity .
loading...
    loading...
8
8 Cited Publications
製品番号: HY-19870
CAS 番号: 920014-72-8
別名: RM-493; Bim-22493; IRC-022493
Setmelanotide (RM-493) is a blood-brain barrier-permeable, selective MC4R agonist with a Ki value of 2.1 nM for hMC4R. Setmelanotide activates the CaMKK2/AMPK signaling pathway. Setmelanotide mediates body weight homeostasis, feeding regulation and energy expenditure modulation; it reduces food intake, induces weight loss, decreases obesity severity, increases daytime activity and energy expenditure, lowers levels of leptin, triglycerides, fasting insulin and diastolic blood pressure, improves insulin sensitivity, glucose tolerance and fatty liver condition, and reverses respiratory depression. Setmelanotide is applicable to research related to obesity, hyperinsulinemia, fatty liver and respiratory depression .
loading...
    loading...
8
8 Cited Publications
製品番号: HY-19870C
CAS 番号: 2759937-80-7
別名: RM-493 monoacetate; Bim-22493 monoacetate; IRC-022493 monoacetate
Setmelanotide monoacetate (RM-493 monoacetate) is a blood-brain barrier-permeable, selective MC4R agonist with a Ki value of 2.1 nM for hMC4R. Setmelanotide monoacetate activates the CaMKK2/AMPK signaling pathway. Setmelanotide monoacetate mediates body weight homeostasis, feeding regulation and energy expenditure modulation; it reduces food intake, induces weight loss, decreases obesity severity, increases daytime activity and energy expenditure, lowers levels of leptin, triglycerides, fasting insulin and diastolic blood pressure, improves insulin sensitivity, glucose tolerance and fatty liver condition, and reverses respiratory depression. Setmelanotide monoacetate is applicable to research related to obesity, hyperinsulinemia, fatty liver and respiratory depression .
loading...
    loading...
3
3 Cited Publications
製品番号: HY-108742
CAS 番号: 247062-33-5
純度:  99.91%
別名: BA 058; Bim 44058
Target:  

PTHR Arrestin

研究分野:  

Metabolic Disease Cancer

Abaloparatide (BA 058) is a parathyroid hormone receptor 1 (PTHR1) analog. Abaloparatide also is a selective PTHR1 activator. Abaloparatide enhances Gs/cAMP signaling and β-arrestin recruitment. Abaloparatide enhances bone formation and cortical structure in mice. Abaloparatide has the potential for the research of osteoporosis .
loading...
    loading...
3
3 Cited Publications
製品番号: HY-114989
CAS 番号: 1362243-70-6
純度:  99.77%
Target:  

Apoptosis

研究分野:  

Cancer

Fluorizoline selectively and directly binds to prohibitin 1 (PHB1) and 2 (PHB2), and induces apoptosis. Fluorizoline reduces chronic lymphocytic leukemia (CLL) cell viability through the upregulation of NOXA and BIM. Fluorizoline exerts antitumor action in a p53-independent manner .
loading...
    loading...
3
3 Cited Publications
製品番号: HY-108742A
純度:  99.86%
別名: BA 058 TFA; Bim 44058 TFA
Target:  

Arrestin PTHR

Abaloparatide TFA (BA 058 TFA) is a parathyroid hormone receptor 1 (PTHR1) analogue. Abaloparatide TFA also is a selective PTHR1 activator. Abaloparatide TFA enhances Gs/cAMP signaling and β-arrestin recruitment. Abaloparatide TFA enhances bone formation and cortical structure in mice. Abaloparatide TFA has the potential for the research of osteoporosis .
loading...
    loading...
2
2 Cited Publications
製品番号: HY-129179
CAS 番号: 2180923-05-9
純度:  99.28%
別名: APG-2575; Bcl-2/Bcl-xl inhibitor 1
Target:  

Bcl-2 Family Apoptosis

研究分野:  

Cancer

Lisaftoclax is an orally active, selective BCL-2 inhibitor with a Ki of < 0.1 nM against human BCL-2. Lisaftoclax selectively binds to BCL-2, disrupts the BCL-2:BIM complex, and antagonizes the antiapoptotic function of BCL-2. Lisaftoclax induces BAX/BAK-dependent, caspase-mediated apoptosis, upregulates the pro-death proteins BIM and Noxa, and downregulates mitochondrial respiratory function and ATP production. Lisaftoclax can be used in the research of hematological malignancies including chronic lymphocytic leukemia, multiple myeloma, and diffuse large B-cell lymphoma .
loading...
    loading...
2
2 Cited Publications
製品番号: HY-19884B
CAS 番号: 2863659-22-5
別名: RM-131 TFA; Bim-28131 TFA
Target:  

GHSR

研究分野:  

Metabolic Disease

Relamorelin (RM-131) TFA, a pentapeptide ghrelin analog, is a selective ghrelin/growth hormone secretagogue receptor (GHSR) agonist with a Ki of 0.42 nM for GHS-1a receptor. Relamorelin TFA is centrally penetrant. Relamorelin TFA increases growth hormone levels and accelerates gastric emptying. Relamorelin TFA has the potential for cachexia, gastroparesis, and gastric/intestinal dysmobility disorders research .
loading...
    loading...
2
2 Cited Publications
製品番号: HY-10499
CAS 番号: 892546-37-1
純度:  99.88%
別名: Bim-46187
PH-064 (BIM-46187) is an orally active inhibitor of the heterotrimeric G-protein complex. PH-064 inhibits SERT activity and attenuates shear stress-induced Akt phosphorylation. PH-064 has potent anti-hyperalgesia activity. PH-064 inhibits G protein-coupled receptor-dependent tumorigenesis. PH-064 can be used in the study of pain (e.g., inflammatory pain, neuropathic pain), GPCR-dependent tumors, and inflammatory lung injury .
loading...
    loading...
2
2 Cited Publications
製品番号: HY-108136A
CAS 番号: 145317-11-9
純度:  98.90%
別名: Bim-X hydrochloride; Ro31-8425 hydrochloride
Bisindolylmaleimide X hydrochloride(Ro 31-8425 hydrochloride, BIM-X hydrochloride) is a cell-penetrating PKC inhibitor. Bisindolylmaleimide X hydrochloride is a potent cyclin-dependent kinase 2 (CDK2) antagonist with an IC50 of 200 nM. Bisindolylmaleimide X hydrochloride inhibits the proliferation of CD4 T cells in vitro. Bisindolylmaleimide X hydrochloride inhibits eNOS-Ser1177 phosphorylation in human embryonic vein endothelial cells. Bisindolylmaleimide X hydrochloride can be used for research on the immune system and cardiovascular diseases .
loading...
    loading...
2
2 Cited Publications
製品番号: HY-P1527
CAS 番号: 505070-06-4
Target:  

Bcl-2 Family

研究分野:  

Others

Bim BH3 is a biological active peptide. (This Bim peptide belongs to the pro-apoptotic Bcl-2 family of proteins.)
loading...
    loading...
1
1 Cited Publications
製品番号: HY-15191
CAS 番号: 1228108-65-3
純度:  99.04%
別名: BI-97C1
Target:  

Bcl-2 Family

研究分野:  

Cancer

Sabutoclax is a potent and effective Bcl-2 Family (Bcl-2, Bcl-XL, Mcl-1, Bfl-1) inhibitor with IC50s of 0.32 μM, 0.31 μM, 0.20 μM, and 0.62 μM, respectively. Sabutoclax increases Bax, Bim, PUMA and survivin expression .
loading...
    loading...
1
1 Cited Publications
製品番号: HY-145162
CAS 番号: 2458219-65-1
純度:  95.83%
研究分野:  

Cancer

SHP2-D26 is a SHP2 PROTAC degrader with DC50 values of 6.0 nM (KYSE520 cells) and 2.6 nM (MV4;11 cells), respectively. SHP2-D26 inhibits ERK phosphorylation, upregulates Bim levels, downregulates Mcl-1 levels, and induces cell cycle arrest and apoptosis. SHP2-D26 can be used in studies related to esophageal cancer, acute myeloid leukemia and non-small cell lung cancer .
loading...
    loading...
1
1 Cited Publications
製品番号: HY-103277A
純度:  96.20%
BIM 23042 TFA, a certain somatostatin (SS) octapeptide analogue, is a selective neuropeptide neuromedin B receptor (NMB-R, BB1) antagonist. BIM 23042 has 100-fold lower affinity for gastrin-releasing peptide (GRP) receptor (BB2). BIM 23042 inhibits Neuromedin?B?(HY-P0241), ICI 216140 and DPDM-bombesin ethylamide-induced Ca 2+ release .
loading...
    loading...
製品番号: HY-P1959
CAS 番号: 108736-35-2
別名: Bim 23014
Target:  

Somatostatin Receptor

研究分野:  

Endocrinology Cancer

Lanreotide (BIM 23014) is a somatostatin analogue with antineoplastic activity. Lanreotide can be used for the research of carcinoid syndrome .
loading...
    loading...
製品番号: HY-P1959A
CAS 番号: 2378114-72-6
別名: Bim 23014 acetate
Target:  

Somatostatin Receptor

研究分野:  

Endocrinology Cancer

Lanreotide (BIM 23014) acetate is a somatostatin analogue with antineoplastic activity. Lanreotide acetate can be used for the research of carcinoid syndrome .
loading...
    loading...
製品番号: HY-P1889
CAS 番号: 721885-31-0
Target:  

Bcl-2 Family Amyloid-β

研究分野:  

Neurological Disease

Bim BH3, Peptide IV is an Aβ42-binding peptide and the pro-apoptotic BH3 domain of the BIM protein. Bim BH3, Peptide IV binds Aβ42 with a Kd of 7.1 μM. Bim BH3, Peptide IV modulates Aβ42 structure, fibrillization pathways, aggregate morphology, and membrane interactions, inhibiting fibril formation while enhancing protofibril assembly. Bim BH3, Peptide IV promotes Aβ42 β-sheet formation and accelerates aggregation. Bim BH3, Peptide IV enhances Aβ42 membrane internalization and bilayer stiffening. Bim BH3, Peptide IV induces neuronal cell death by enhancing BH3-induced membrane interactions of Aβ42 prefibrillar species. Bim BH3, Peptide IV can be used for research on Alzheimer's disease .
loading...
    loading...
製品番号: HY-P1203
CAS 番号: 150155-61-6
Target:  

Somatostatin Receptor

研究分野:  

Neurological Disease

BIM 23056, a linear octapeptide, is a potent sst3 and sst5 somatostatin receptor antagonist with Ki values of 10.8, 5.7, respectively .
loading...
    loading...
製品番号: HY-P0165
CAS 番号: 275371-94-3
別名: ITM077; R1583; Bim51077
Target:  

GCGR

研究分野:  

Metabolic Disease

Taspoglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist developed for treatment of type 2 diabetes, with an EC50 value of 0.06 nM.
loading...
    loading...